% | $
Quotes you view appear here for quick access.

Avanir Pharmaceuticals, Inc. Message Board

  • greatdayforinvestments greatdayforinvestments Oct 7, 2013 1:42 PM Flag

    Bill Sibold left Avanir to launch Genzyme's MS drugs! Yep, Bill served less than a yr previous to Avanir as a CEO:

    Bill Sibold is responsible for Genzyme’s Multiple Sclerosis franchise as the company prepares to launch two products.

    Prior experience:

    Senior Vice President and Chief Commercial Officer, Avanir Pharmaceuticals
    President and Chief Executive Officer, Lycera Corporation

    "The CEO of Lycera, one of Michigan’s high-profile biotech startups, has left the company after less than a year on the job. CEO Bill Sibold, the former Biogen Idec executive who was hired to lead the Plymouth, MI-based startup in January, has resigned to pursue other interests, Xconomy has confirmed."

    “Bill is a senior and experienced biotech executive with an excellent track record at Biogen, but both he and the board felt that the fit was not optimal with a heavily science based company like Lycera,” said Jeff Leiden, Lycera’s chairman, in an e-mailed statement.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies